These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12833567)

  • 1. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model.
    Bourhim M; Darnige L; Legallais C; Arvieux J; Cevallos R; Pouplard C; Vijayalakshmi MA
    J Mol Recognit; 2003; 16(3):125-30. PubMed ID: 12833567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
    Vlachoyiannopoulos PG; Routsias JG
    J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
    Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
    Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
    Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
    Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
    Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
    J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR; Martinuzzo ME; Cerrato GS; Kordich LC; Carreras LO
    Thromb Haemost; 1997 Sep; 78(3):1008-14. PubMed ID: 9308745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
    Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
    Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
    Sikara MP; Routsias JG; Samiotaki M; Panayotou G; Moutsopoulos HM; Vlachoyiannopoulos PG
    Blood; 2010 Jan; 115(3):713-23. PubMed ID: 19805618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding.
    George J; Gilburd B; Hojnik M; Levy Y; Langevitz P; Matsuura E; Koike T; Shoenfeld Y
    J Immunol; 1998 Apr; 160(8):3917-23. PubMed ID: 9558098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution.
    Tincani A; Spatola L; Prati E; Allegri F; Ferremi P; Cattaneo R; Meroni P; Balestrieri G
    J Immunol; 1996 Dec; 157(12):5732-8. PubMed ID: 8955227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.
    Blank M; George J; Barak V; Tincani A; Koike T; Shoenfeld Y
    J Immunol; 1998 Nov; 161(10):5303-12. PubMed ID: 9820503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
    Yasuda S; Atsumi T; Ieko M; Koike T
    Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfatides: targets for anti-phospholipid antibodies.
    Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P
    Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
    Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
    Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.